(Q43845713)

27 November 2017

title

Unit differences in pathogen occurrence arising from the MYSTIC program European database (1997-2000). (English)

1 reference

27 November 2017

C Mendes

1

1 reference

27 November 2017

P J Turner

series ordinal

2

1 reference

27 November 2017

MYSTIC Study Group (Europe)

series ordinal

3

1 reference

27 November 2017

publication date

1 December 2001

1 reference

Diagnostic Microbiology and Infectious Disease

27 November 2017

published in

1 reference

27 November 2017

volume

41

1 reference

27 November 2017

issue

4

1 reference

27 November 2017

page(s)

191-196

1 reference

Focused microbiological surveillance and gram-negative beta-lactamase--mediated resistance in an intensive care unit.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

Meropenem: a microbiological overview

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

Emerging mechanisms of fluoroquinolone resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

Determining the value of antimicrobial surveillance programs

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European university hospitals. SENTRY Participants Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

The MYSTIC (meropenem yearly susceptibility test information collection) programme.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

A multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens in the United States, 1992-1994. The Alexander Project

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900321-2

7 January 2021

10.1016/S0732-8893(01)00321-2

Identifiers

DOI

1 reference

27 November 2017

1 reference